Franek Technologies has configured an uninterruptible power supply unit to support the Applied Biosystems Prism® 7500 Real-Time PCR Sequence Detector with Controller
The family of ultra-flat Krystal glass bottom microplates from Porvair Sciences provide unmatched performance for high-throughput screening and tissue culture applications
Henry Schein Medical, the U.S. medical business of Henry Schein, Inc., announced recently its new private label-branded product, OneStep + Pro Hb Analyzer, a portable, reagent-free hemoglobin analyzer, which measures hemoglobin concentration as a result of a fingerstick blood test
Titan Enterprises announces new software functionality for its Atrato and MetraFlow ultrasonic flowmeters to enable customers the option to move the measurement window to ensure you always measure at the optimal point of signal
Uniqsis reports on how its Flow-UV inline UV-Visible spectrometer sets a new benchmark for real-time dispersion and nanoparticle distribution and agglomeration experiments
The results of a pilot study using Longhorn Vaccines and Diagnostics's patented sample collection technology, PrimeStore® MTM, were presented at the 29th European Congress of Clinical Microbiology & Infectious Diseases in Amsterdam, Netherlands, by Professor Bernard Fourie PhD of the University of Pretoria, South Africa
SP Scientific’s Genevac EZ-2 Centrifugal Evaporator is providing the Clinical Biochemistry department at a leading UK hospital with a reliable, easy-to-use method of preparing clinical samples ready for testing
FLIR Systems has introduced FLIR Research Studio, a new thermal imaging software for Research and Development (R&D) and science professionals
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today launched three new sexually transmitted disease (STD) laboratory test packages that individuals can purchase online for some of the most prevalent STDs in the United States
Columbia University and Project ALS today announced the Project ALS Therapeutics Core at Columbia, a 3-year, $6.3M initiative toward the first meaningful therapies for ALS
|
|
|
|
|
|
|
|
|